AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
, 2025, . , reflecting significant short-term momentum amid elevated market participation.
Recent developments suggest renewed institutional interest in the healthcare technology sector, with Hims benefiting from broader thematic flows. The surge in volume indicates a potential shift in investor sentiment, though sustainability of gains remains contingent on follow-through buying. Technical indicators show the stock has broken above key resistance levels, attracting algorithmic and discretionary traders alike.
To run this back-test robustly, I need to pin down a few practical details about how the strategy should be built and what data
we should rely on. Once these are clear I can fetch the right data and run the test for you.1. Universe: Should the strategy screen from the entire U.S. listed equities universe (NYSE + NASDAQ + Amex) or a narrower list like the Russell 3000 constituents?
2. Ranking basis & timing: "Top 500 stocks by daily trading volume" – should this ranking be based on yesterday’s volume, then positions are opened at today’s open and liquidated at today’s close (≈1-day holding period)?
3. , , or something else? Any commission/slippage you’d like applied, or assume frictionless trading?
4. , sell at close), , ?
Once I have these points, .

Hunt down the stocks with explosive trading volume.

Dec.26 2025

Dec.26 2025

Dec.26 2025

Dec.26 2025

Dec.26 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet